| Application no. and date | 12722057.2 (espacenet) (Federated) (European Patent Register), 20120514 | | Patent/reg. no. and date | DK/EP 2707385, 20170920 | | Publication date | 20140319 | | Priority no. and date | US 201161486005 P, 20110513 | | EP pub. no. and date |
EP 2707385 20140319 | | Effective date | | | Applicant/owner | GlaxoSmithKline Biologicals SA, Rue de l'Institut 89
1330 Rixensart, BE | | Applicant ref. no. | 160962 | | Inventor | SWANSON, Kurt, c/o Novartis Vaccines And Diagonstics Inc.
P.O. Box 8097
Emeryville, CA 94662-8097, US,
CARFI, Andrea, c/o Novartis Vaccines And Diagonstics Inc.
P.O. Box 8097
Emeryville, CA 94662-8097, US | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | C07K 14/135 (2006.01) | | Title | RSV-F-præfusionsantigener | | Int. application no. | US2012037773 | | Int. publication no. | WO2012158613 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
